Thank you. Good morning. Thank you for joining us for our 2023 annual year earnings call. Here is Ron Freund, our Chief Financial Officer. We will begin by providing you with an overview of our business and the summary of the principal factors that affected our results during 2023. After our prepared remarks, we will be happy to answer any of your questions. By now, everyone should have access to our press release, which was released earlier today. The release will also be available on our website. In 2023, the company achieved unprecedented milestone in terms of both revenue and profitability, setting new records. The company generated revenue of $46.7 million with net income of $6.4 million. EBITDA reached $8.6 million. The cash flow from operations stood at $8.9 million. Remarkably, all key profitability indicator experienced substantial growth rate underscoring the success of our strategic cost initiatives. The ongoing situation in Israel, coupled with the presidents rise in the defense budget across European nations and the trade tension between the U.S. and China continue to influence the demand of our high-end products. Since the inspection of our accelerated investment plan in 2022, our backlog had increased by 130%. The growing demand persists, and we anticipate that the trend to extend into the upcoming years. While the influence of the current conflict in Israel has not been fully manifested our backlog. We expected more pronounced impact to become evident later in the second half of 2024. We have achievably diversified our revenue streams by exploring opportunities beyond the defense and medical devices market. Our focus includes strengthening collaboration and securing substantial orders for new products with a leading customer whose machinery and technology play a crucial role in the large-scale production of semiconductor chips. Currently, effort has been underway to augment our commercial sales volume. Our approach to pricing and order acceptance remains as a key focus as we continue to optimize this strategy to achieve optimal profitability rates. We are actively progressing with execution of our accelerated investment plan. To date, we have committed to an approximately investment of $10 million, and we anticipate fulfilling orders for the entire plan by the end of 2024. In the first quarter of 2024, the machine mentioned in our December '23 press release, were received and installed and the [VFV] line is currently under commissioning stages. We additionally installed additional press, which is a significant component of the accelerated investment plan. The press is in final installation stages and the software adjustments. Furthermore, we successfully implemented cutting-edge engineering software. During Q1 2024, we plan to complete the training of our engineers. This software is a position to us at the front end of the technological advancement in this field. We have initiated the construction of new office space within our building in Petah Tikva. This move seeks to optimize office utilization, freeing up space for expanded production capacity. By doing so, we aim to seamlessly integrate new production lines without incurring additional overhead expenses for the existing infrastructure. As a result of the securities challenges in Israel and the logistical issue entering the shipment of the arrival of the supplier technical team to the country, we anticipate potential delay of the accelerated investment program. We are actively dedicating significant efforts to try to mitigate these delays. In our pursued expansion of the growth, we are actively seeking for acquired PCB manufacturing company in United States, recognize the strategic importance of the U.S. market, we anticipate substantial growth in the upcoming years. The underlying motivation behind the chips in the PCB Act to repatriate chips and PCB production to America for seeing increased demand for the domestic PCB manufacturing. Contextually, we are focused on augmenting production capacity in the U.S. In February 2024, we raised capital of $10 million before expenses. This amount will be used by us together with our existing cash balances for the purpose of financing continuous growth. I would like to take this opportunity to thanks to the investors who participated in the offering for the trust they placed in our company and its management. The successful capital raising and the fact that during 2023, we have repaid all our bank debt loan will allow us to finance a future M&A transaction -- raising debt either from the bank or from the public. I will now turn the call over to Ron Freund, our CFO, to discuss our financial results.
